Evicenter
P&T meetings

RP-A501 (AAV9.LAMP2B)

Danon disease

Regulatory submission
BLA planned for late 2028
Last updated
300 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Danon disease

Economic impact of Danon disease on families

7 evidence topics · 10 sources

Caregiver time, work loss, and out-of-pocket cost: published studies

No evidence found.